Related Experiment Video
Updated: Jun 5, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
C-reactive protein and chronic hepatitis C virus infection in diabetic patients
Marcin Skowroński1, Dorota Zozulińska-Ziółkiewicz, Jacek Juszczyk
1Department of Internal Medicine and Diabetology, Poznan University of Medical Science, Poznań, Poland. marcinas@gazeta.pl
Insights
Hepatitis C virus (HCV) infection may alter inflammation markers in diabetic patients. Screening for HCV is recommended before cardiovascular risk assessment in diabetics, as it impacts scoring.
Area of Science:
- Cardiology
- Hepatology
- Diabetology
Background:
- C-reactive protein (CRP) is a key cardiovascular disease risk marker.
- The role of hepatitis C virus (HCV) infection in diabetic inflammation and cardiovascular risk is unclear.
Purpose of the Study:
- To investigate the relationship between HCV infection and CRP levels in diabetic patients.
- To assess HCV's impact on cardiovascular risk markers in diabetes.
Main Methods:
- Compared CRP and inflammatory markers in four groups: HCV+diabetes, HCV-negative type 1 diabetes, HCV-negative type 2 diabetes, and HCV+no diabetes.
- Analyzed C-reactive protein (CRP), white blood cell count, and erythrocyte sedimentation rate.
Main Results:
- Diabetic HCV patients had lower CRP than type 2 diabetics but similar to type 1 diabetics.
- White blood cell counts were lower in diabetic HCV patients compared to type 2 diabetics.
- Erythrocyte sedimentation rate differed between diabetic and non-diabetic HCV groups.
Conclusions:
- HCV infection may modulate the chronic inflammatory state in diabetic patients.
- Consider HCV screening before cardiovascular risk assessment in diabetics.
- HCV status can influence cardiovascular risk scoring in diabetic populations.
Introduction:
C-reactive protein (CRP) is one of the most widely used risk markers of cardiovascular disease in clinical practice. The contribution of hepatitis C virus (HCV) infection to low-grade inflammation in diabetic patients and its significance for cardiovascular risk scoring remain unclear.
Objectives:
The aim of the study was to investigate the relationship between HCV infection and CRP levels as one of the markers of cardiovascular risk in diabetic patients.
Patients And Methods:
we compared patients with HCV infection and diabetes (n = 46) with HCV-negative type 1 (n = 56) or type 2 diabetic patients (n = 54), as well as HCV patients without diabetes (n = 54).
Results:
CRP levels in diabetic HCV patients were lower than in type 2 diabetic patients (P <0.001), similar to those in the type 1 diabetic group (P = 0.747), and higher than in nondiabetic HCV subjects (P = 0.002). The median values were 1.07, 2.58, 0.91, and 0.45 mg/l, respectively. White blood cell count in diabetic HCV subjects was lower than in those with type 2 diabetes (P = 0.029) and similar to that found in type 1 diabetic (P = 0.064) and nondiabetic HCV patients (P = 0.279). There was difference in erythrocyte sedimentation rate between diabetic and nondiabetic HCV groups (P = 0.025); the respective medians were 10 and 5 mm/h.
Conclusions:
these findings indicate that HCV hepatitis may modulate chronic inflammatory state in diabetic patients. Moreover, these results suggest that screening for HCV should be considered prior to assessment of cardiovascular risk in diabetic patients, because the results may affect the cardiovascular risk scoring.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis II: Pathophysiology
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
